SenzaGen has signed agreements with CRO companies GV Research Platform (GVRP) in India and Oroxcell in France for the distribution of the company's non-animal test portfolio, GARD®? for chemical risk assessment. These strategic partnerships will enable the broadened distribution of GARD®?

to key markets driven by regulatory and industrial demand for alternative testing methods. India is a potentially important and large market where SenzaGen has already noticed increased interest in GARD®? and has successfully secured orders from Indian customers.

By collaborating with GVRP, a prominent CRO and distribution company in India, SenzaGen now gains access to a robust network and expertise in the country's thriving Life Science sector. Similarly, SenzaGen's partnership with Oroxcell, an well-established CRO in France, strengthens the company's presence in one of its key geographic markets. France, known for its companies in cosmetics and pharmaceuticals, has long upheld a ban on animal testing for cosmetics as a member of the EU.

With Oroxcell's strong focus on innovative, animal-free methods, SenzaGen will benefit from their broad network of contacts and specialist knowledge. Both distributors will actively promote GARD®? in their test portfolio, with a focus on biotech, pharma, chemical, and cosmetic companies seeking advanced testing solutions.

All tests will be conducted at SenzaGen's GLP certified laboratory in Lund, Sweden.